-
Logged in as
- My Dashboard
- My Profile
- Settings
- Logout
23 December 2019
We are delighted to announce that Jayne Mellor, Director of Transformation and Delivery, Chorley and South Ribble CCG & Greater Preston CCG, will be joining the NHSCC board as a representative for the North West region.
18 December 2019
NHS Clinical Commissioners and Local Government Association have developed an interactive discussion guide to assist clinical commissioning groups (CCGs) and local government colleagues to have open conversations and identify any issues that may arise as CCGs prepare to merge.
20 November 2019
Get involved and join the many voices calling on politicians to fix social care.
19 November 2019
Health leaders across England have urged the incoming Government to address the critical issues that will improve and transform services for patients
06 November 2019
We were delighted to see some of our members celebrated as award winners at the HSJ Awards.
06 November 2019
We are pleased to have partnered again with the Self Care Forum to promote Self Care Week 2019.
14 October 2019
Today the Queen set out the Government’s agenda of legislation for the new session of Parliament, including a draft bill designed to help to implement the NHS Long Term Plan.
30 September 2019
NHSCC’s chief executive Julie Wood has been recognised on the Pf Power List 2019 for her work influencing the political landscape on behalf of clinical commissioners.
26 September 2019
Responding to proposals published today, Julie Wood, chief executive of NHSCC said: “We are pleased to lend our support to the recommendations being put forward by NHS England/Improvement for an NHS Bill… This legislation will speed up the integration of care and remove the inefficient parts of the system that distract from delivery of the best possible care.”
19 September 2019
Responding to the MHRA’s revised position on the use of Avastin, NHSCC’s chief executive Julie Wood said: “We are delighted to see MHRA has revised its position on the use and supply of Avastin to treat wet AMD. This decision is a step towards enabling the NHS to treat thousands of patients with wet AMD for a fraction of the cost, freeing much-needed funds to spend on other NHS services.”
